Trial Profile

Treatment of Mycosis Fungoides with Hypericin Ointment and Visible Light

Status: Recruiting

Phase of Trial: Phase II

Latest Information Update: 11 Mar 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Hypericin sodium (Primary)
Indications Mycosis fungoides
Focus Therapeutic Use
Acronyms RW-HPN-MF-01
Sponsors Soligenix

Most Recent Events

06 Mar 2025 According to a Soligenix media release, company is going to present data which include findings from this study at the United States Cutaneous Lymphoma Consortium (USCLC) Workshop (March 6, 2025).
22 Jan 2025 Planned number of patients changed from 50 to 20.
22 Jan 2025 Planned End Date changed from 31 May 2025 to 1 Dec 2026.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com